Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABCD: Azithromycin for Severe Diarrhoea
NCT03130114Phase 3Completed
- Sponsor
- World Health Organization
- Start
- May 2017
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 3, randomised, double-blind trial of azithromycin in acute diarrhea (2 arms), sponsored by World Health Organization. Primary endpoints: All-cause mortality at 180 days and Change in length-for-age z-score at 90 days. Started May 2017; status: completed.
02
Drugs
azithromycin
03
Conditions
acute diarrhea
Beyond the preview
Go deeper on NCT03130114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03130114.